“Efficacy and Safety of Roflumilast Cream 0.15% in Adults and Children Aged ≥6 Years With Mild to Moderate Atopic Dermatitis in Two Phase 3 Trials (INTEGUMENT-1 and INTEGUMENT-2)” (2023) SKIN The Journal of Cutaneous Medicine, 7(4), p. s220. doi:10.25251/skin.7.supp.220.